Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT01316341 Completed - Clinical trials for Diabetes Mellitus, Type 2

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus

Start date: March 2011
Phase: Phase 1
Study type: Interventional

the pharmacokinetics, pharmacodynamics and safety and tolerability of single and multiple oral doses of BI 10773 at low dose once daily (q.d.) and high dose q.d. administered to Chinese female and male patients with type 2 diabetes will be investigated.

NCT ID: NCT01313949 Completed - Diabetes Clinical Trials

PLATINUM Program: A Feasibility Study on a Train-the-trainer Course on Peer Support for People With Type 2 Diabetes

PLATINUM
Start date: February 2009
Phase: N/A
Study type: Interventional

The investigators hypothesize that a training course to people with diabetes on peer support and empowerment will improve their glycemic parameters, knowledge on diabetes and level of self efficacy. This group of trained patients (peer leaders) should be competent to teach and help other patients with diabetes through peer support and empowerment on better self management of their diabetes.

NCT ID: NCT01310556 Completed - Diabetes Mellitus Clinical Trials

Unknown Glucose Metabolism Disorders In Patients With Coronary Artery Disease

Start date: June 2009
Phase: N/A
Study type: Observational

This study aimed to examine the prevalence of glucose metabolism disorders (GMD)in the patients with coronary artery disease and the relationship between different GMDs and coronary artery disease (CAD).

NCT ID: NCT01308008 Completed - Clinical trials for Diabetes Mellitus Type 2

Home Exercise to Enhance Mobility for Older Diabetics

Start date: November 2011
Phase: N/A
Study type: Interventional

The goal of the proposed research is to test whether a long-term exercise program in sedentary Veterans with diabetes will produce sustained improvement in mobility performance and physical activity. In this proposed research, 240 sedentary older adult diabetics (aged 60 and over) will be randomly allocated into a customized, primarily home-based, functionally-oriented exercise program with nurse support intervention (I) group versus a flexibility and toning, health education control (C) group, and test outcomes in functional mobility and physical activity at 4 weeks, 6 months and one year. This research can lead to an exercise/PA enhancement program that can coordinate with VA outreach programs, targeting older Veterans who are not in the immediate vicinity of a major VA site. Ultimately, this should create a model to which physicians and other providers could refer comorbid diabetes patients.

NCT ID: NCT01307904 Completed - Diabetes Mellitus Clinical Trials

The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects

Dates
Start date: March 2010
Phase: Phase 0
Study type: Interventional

The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study. The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%). The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items.

NCT ID: NCT01306214 Completed - Obesity Clinical Trials

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

Start date: February 2011
Phase: Phase 3
Study type: Interventional

This trial will evaluate use of BI 10773 as add-on to insulin regimen alone or with metformin in patients with typr 2 diabetes. Both lowering glucose and HbA1c and reducing the use of insulin in this population would provide significant new information for the BI 10773 use and would offer a potential new therapeutic option in this population.

NCT ID: NCT01306110 Completed - Diabetes Clinical Trials

Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study

DIABSCAN
Start date: June 2007
Phase: N/A
Study type: Observational

The aim of this study is to evaluate liver fibrosis using FibroScan and biochemical markers in patients with diabetes.

NCT ID: NCT01305434 Completed - Clinical trials for Diabetes Mellitus Type 2

Mulberry Leaf Extract and Blood Glucose Control in Diabetics

Start date: September 2011
Phase: Phase 1/Phase 2
Study type: Interventional

Mulberry leaf teas or extracts are used as a natural remedy for diabetes in some countries. Animal studies have shown some effect of mulberry leaf extract on blood glucose. The purpose of this trial is to assess the effect of mulberry leaf extract on type 2 diabetics, by measuring blood glucose two hours after eating a meal and taking a capsule containing either mulberry leaf extract or a placebo.

NCT ID: NCT01305005 Completed - Hypertension Clinical Trials

Effect of Phacoemulsification on Ocular Blood Flow in Human

Start date: March 2011
Phase:
Study type: Observational

- To investigate ocular haemodynamics after phacoemulsification surgery - To evaluate the influence in people with different autoregulation of ocular blood flow

NCT ID: NCT01303302 Completed - Clinical trials for Diabetes Mellitus, Type 2

The TANTALUS® II for the Treatment of Type 2 Diabetes

Crossover
Start date: April 2008
Phase: N/A
Study type: Interventional

Evaluation of the safety and efficacy of gastric contractility modulation (GCM) stimulation using the TANTALUS System in the improvement of glycemic control measured by changes in HbA1c. Effects of GCM on weight loss and associated co-morbid conditions will also be evaluated